C5 (UK) will be
holding its 9th Annual International Maximising Pharmaceutical Patent Life
Cycles conference on June 23-24, 2010 in London, England.  The conference will provide insights
on:

• How to profit
from the latest regulatory protections available to extend patent lifecycles;
• How to adjust
patent strategy to developments in key pharma patent cases in the UK and
Europe;
• The scope of SPC
protection and analysis of key definitions in SPC Regulation that have given
rise to litigation;
• How second
medical use claims and dosage regimes can be used to extend patent
lifecycles:  Consequences of G2/08;
• European and U.S.
standards for biosimilars:  Where
are we now?
• How to know when
to file to maximize regulatory and patent protection with a critical update on
the EPO rule changes;
• How the
Commission sector inquiries and follow-on investigations have changed the
landscape for patent settlements?
• The
practicalities of obtaining preliminary injunctions in pharma patent cases in
the English Courts.

In particular, C5
faculty will offer presentations on the following topics:

• Update on the
regulatory protections available to extend your patent lifecycles:  Comparing and contrasting Europe and
the U.S.;
• "Raising the
bar":  How the EPO's new
standards and rule changes impact your lifecycle strategy;
• Filing your
patents strategically to extend patent lifecycles;
• Adjusting your
patent strategy to developments in pharmaceutical patent protection:  Key cases in the UK and Europe;
• Second medical
use claims and dosing regimes: 
Consequences of G2/08;
• Supplementary
Protection Certificates (SPCs): 
Where do we stand and what does the future hold?
• Patent
settlements, product launches, and pricing issues under EU and U.S. law:  What is the current state of play?
• U.S. major case
law and policy developments;
• Biosimilars —
Where are we now:  Comparing and
contrasting European and U.S. standards;
• Mechanisms for
dispute resolution:  Mediation,
arbitration, or litigation?
• Obtaining
preliminary injunctions and calculating their worth in pharma patent cases in
the English courts.

A complete brochure
for this conference, including an agenda, list of speakers, and registration
form can be downloaded here.

The registration
fee for the conference is £1399 ($2,071.06). 
Those interested in registering for the conference can do so here, by calling +44 (0)
20 7878 6888, by faxing a registration form to +44 (0) 20 7878 6896, or by
e-mailing registrations@C5-Online.com.